Year |
Citation |
Score |
2016 |
Cai Z, Chattopadhyay N, Yang K, Kwon YL, Yook S, Pignol JP, Reilly RM. (111)In-labeled trastuzumab-modified gold nanoparticles are cytotoxic in vitro to HER2-positive breast cancer cells and arrest tumor growth in vivo in athymic mice after intratumoral injection. Nuclear Medicine and Biology. 43: 818-826. PMID 27788375 DOI: 10.1016/J.Nucmedbio.2016.08.009 |
0.598 |
|
2016 |
Pu K, Chattopadhyay N, Rao J. Recent advances of semiconducting polymer nanoparticles in In vivo molecular imaging. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26773769 DOI: 10.1016/J.Jconrel.2016.01.004 |
0.356 |
|
2015 |
Pu K, Mei J, Jokerst JV, Hong G, Antaris AL, Chattopadhyay N, Shuhendler AJ, Kurosawa T, Zhou Y, Gambhir SS, Bao Z, Rao J. Diketopyrrolopyrrole-Based Semiconducting Polymer Nanoparticles for In Vivo Photoacoustic Imaging. Advanced Materials (Deerfield Beach, Fla.). 27: 5184-90. PMID 26247171 DOI: 10.1002/Adma.201502285 |
0.448 |
|
2013 |
Cai Z, Pignol JP, Chattopadhyay N, Kwon YL, Lechtman E, Reilly RM. Investigation of the effects of cell model and subcellular location of gold nanoparticles on nuclear dose enhancement factors using Monte Carlo simulation. Medical Physics. 40: 114101. PMID 24320476 DOI: 10.1118/1.4823787 |
0.601 |
|
2013 |
Lechtman E, Mashouf S, Chattopadhyay N, Keller BM, Lai P, Cai Z, Reilly RM, Pignol JP. A Monte Carlo-based model of gold nanoparticle radiosensitization accounting for increased radiobiological effectiveness. Physics in Medicine and Biology. 58: 3075-87. PMID 23594417 DOI: 10.1088/0031-9155/58/10/3075 |
0.562 |
|
2013 |
Chattopadhyay N, Cai Z, Kwon YL, Lechtman E, Pignol JP, Reilly RM. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Research and Treatment. 137: 81-91. PMID 23160926 DOI: 10.1007/S10549-012-2338-4 |
0.593 |
|
2012 |
Chattopadhyay N, Fonge H, Cai Z, Scollard D, Lechtman E, Done SJ, Pignol JP, Reilly RM. Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. Molecular Pharmaceutics. 9: 2168-79. PMID 22734589 DOI: 10.1021/Mp300016P |
0.576 |
|
2011 |
Cai Z, Chattopadhyay N, Liu WJ, Chan C, Pignol JP, Reilly RM. Optimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: comparison with manual counting. International Journal of Radiation Biology. 87: 1135-46. PMID 21913819 DOI: 10.3109/09553002.2011.622033 |
0.454 |
|
2011 |
Lechtman E, Chattopadhyay N, Cai Z, Mashouf S, Reilly R, Pignol JP. Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location Physics in Medicine and Biology. 56: 4631-4647. PMID 21734337 DOI: 10.1088/0031-9155/56/15/001 |
0.624 |
|
2011 |
Lechtman E, Chattopadhyay N, Mashouf S, Cai Z, Reilly R, Pignol J. Gold Nanoparticle Radiosensitization: Optimizing Photon Energy, Nanoparticle Size, and Location for Clinical Translation International Journal of Radiation Oncology*Biology*Physics. 81: S740. DOI: 10.1016/J.Ijrobp.2011.06.1222 |
0.626 |
|
2010 |
Chattopadhyay N, Cai Z, Pignol JP, Keller B, Lechtman E, Bendayan R, Reilly RM. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer. Molecular Pharmaceutics. 7: 2194-206. PMID 20973534 DOI: 10.1021/Mp100207T |
0.59 |
|
2010 |
Wong HL, Chattopadhyay N, Wu XY, Bendayan R. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. Advanced Drug Delivery Reviews. 62: 503-17. PMID 19914319 DOI: 10.1016/J.Addr.2009.11.020 |
0.302 |
|
2010 |
Lechtman E, Pignol J, Keller B, Ravi A, Chattopadhyay N, Cai Z, Reilly R. Gold Nanoparticle Radiosensitization is Most Efficient in the Brachytherapy Energy Range Brachytherapy. 9: S46-S47. DOI: 10.1016/J.Brachy.2010.02.061 |
0.623 |
|
2008 |
Chattopadhyay N, Zastre J, Wong HL, Wu XY, Bendayan R. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharmaceutical Research. 25: 2262-71. PMID 18516666 DOI: 10.1007/S11095-008-9615-2 |
0.32 |
|
Show low-probability matches. |